BCEL — Atreca Income Statement
0.000.00%
- $4.06m
- -$17.32m
- 10
- 50
- 14
- 14
Annual income statement for Atreca, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 39.6 | 72.6 | 88.9 | 110 | 98.7 |
Operating Profit | -39.6 | -72.6 | -88.9 | -110 | -98.7 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -37.9 | -67.5 | -86.3 | -109 | -97.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -37.9 | -67.5 | -86.3 | -109 | -97.2 |
Net Income Before Extraordinary Items | |||||
Net Income | -37.9 | -67.5 | -86.3 | -109 | -97.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -37.9 | -67.5 | -86.3 | -109 | -97.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.42 | -2.41 | -2.7 | -2.95 | -2.51 |
Dividends per Share |